PROFHILO H+L (1x2ml) IBSA

PROFHILO H+L (1x2ml) IBSA

STRICT MEDICAL USE IN MEDICAL OFFICES. Authorized status. Medical device CLASS III. European CE marking.

PROFHILO SPECIFICITIES

• OBJECTIVE OF TREATMENT / INDICATION: BIOREMODELLING OF CUTANEOUS LAXITY.
• AREA: FACE. NECK. LOW-CUT.
• HA CONCENTRATION: 64 MG FOR 2 ML.
• HYDRO ACTION: 5/5
• LIFT ACTION: 3/5
• PACKAGING: 2 ML SYRINGE.
• NEEDLE: 29G THIN WALL x 13mm.
• PROTOCOL: 2 SESSIONS. Evaluation 2 months after the last treatment. If necessary repeat the treatment.
• SUGGESTED TECHNIQUE: BAP.
• INJECTION LAYER: DEEP DERMIS.

DESCRIPTION

• IBSA's Hyaluronic Acid is an ultrapure hyaluronic acid, produced by a patented bio-fermentation process of Streptococcus Zooepidemicus, rated worldwide as "Top Quality" in terms of purity, safety and quality. high resistance to thermal production processes.
• The formulation of HA with different molecular weights contained in PROFHILO is based on a concept of Hydrolift Action.
• This innovative approach aims to counter the physiological reduction of HA in the skin, to restore hydration, elasticity and tone of the skin, by combining, in a synergistic way, deep hydration with the mechanical action of lifting the skin. skin.
• It is the first stabilized hyaluronic acid (HA) product that is manufactured without the use of chemical cross-linking agents (BDDE).

INDICATION PROFHILO

• The injectable medical device PROFHILO intervenes in the physiological process of skin aging in the process of repairing dermal tissue in the event of scars resulting from superficial skin trauma.
• PROFHILO is used for skin contouring and the treatment of sagging skin, not just for filler lines and wrinkles.
• With one of the highest concentrations of HA on the market (64mg/2ml), it not only stimulates and hydrates the skin, but also reshapes aging and sagging tissue.

INJECTION AREAS

• PROFHILO is indicated for the treatment of the face and body to redefine contours and reshape laxity.
• However, it is particularly indicated for the treatment of malar-zygomatic, submalar, brachial, abdominal areas and areas affected by sagging skin.

DURABILITY

As a stabilized product, Profhilo lasts in the skin for approximately 28 days.

RESULTS

• Improved fabric quality.
• Skin remodeling.
• Treatment of sagging skin.
• Restoration of skin firmness.

COMPOSITION

Stable hybrid cooperative complexes of low and high molecular weight hyaluronic acid. 3.2% – 32 mg (H-HA) + 32 mg (L-HA)/2 ml Hyaluronic acid sodium salt.

• 3.2% - 16 mg (H-HA) + 16 mg (L-HA)/1 ml hyaluronic acid sodium salt.
• 3.2% - 32mg (H-HA) + 32mg (L-HA)/2ml hyaluronic acid sodium salt.
• Medical device for intradermal use.
• Sterile - Single use.

PRESENTATION

• Pre-filled syringe of 2 ml.
• 2 TERUMO needles type 29G x ½ (29Gx13).
• A product leaflet. 
• 2 product traceability stickers.

IBSA Italia

PROFHILO is manufactured by IBSA Farmaceutici Italia in an FDA approved site in Italy and distributed in the UK and Ireland by HA-Derma Ltd.